In the Press
February 6, 2024

Novo Purchase of Catalent (The Deal)

Catalent agrees to sell to Novo Holdings for a $16.5 billion. Novo Holdings reached Private Equity partner Matt Mauney and Merger and Acquisitions co-chair Joshua Zachariah for counsel, The Deal reports. Novo Holdings, a Copenhagen-based investment company responsible for managing the assets of the Novo Nordisk Foundation. Mauney advised Novo Holdings on its purchases of Paratek Pharmaceuticals Inc. for $462 million last year along with Gurnet Point Capital Ltd.; of KabaFusion LLC from Pritzker Private Capital and of Ritedose Corp. from AGIC Capital GmbH and Humanwell Healthcare Group Co. Ltd. in 2022; and, in 2021, of a minority stake in Availity LLC from Francisco Partners Management LLC and of Altasciences Co. Inc. from Audax Group.